1. Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis

Behnaz Ansari; Masoud Etemadifar; Mohammadreza Najafi; Maryam Nasri; Rokhsareh Meamar

Volume 18, Issue 1 , Winter 2019, , Pages 13-18

Abstract
  Background: This study was designed to investigate the difference in the prevalence of neuronal autoantibodies in patients diagnosed with established temporal lobe epilepsy (TLE) of unknown cause with mesial temporal sclerosis (MTS) and patients with TLE without MTS. Methods: In an observational cohort ...  Read More

2. Demographic features and clinical characteristics of patients with Parkinson’s disease in Isfahan, Iran

Mehri Salari; Omid Mirmosayyeb; Masoud Etemadifar; Vahid Shaygannejad; Fariborz Khorvash; Mohammad Reza Najafi; Fereshteh Ashtari; Ahmad Chitsaz

Volume 17, Issue 1 , Winter 2018, , Pages 6-10

Abstract
  Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Its worldwide incidence rate varies between 18 and 418 cases per 100000 annually. This cross-sectional study was carried out with the aim to identify the clinical characteristics and demographic features of a ...  Read More

3. Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson’s disease, Isfahan, Iran

Mehri Salari; Ahmad Chitsaz; Masoud Etemadifar; Mohammad Reza Najafi; Omid Mirmosayyeb; Maryam Bemanalizadeh; Fatemeh Panahi; Hosna Mirzajani

Volume 16, Issue 3 , Summer 2017, , Pages 118-124

Abstract
  Background: Parkinson’s disease (PD) is diagnosed on the basis of motor symptoms, but non-motor symptoms (NMS) have high prevalence in PD and often antecede motor symptoms for years and cause severe disability. This study was conducted to determine the prevalence of NMS in patients with PD.Methods: ...  Read More